Pila Pharma Danmark ApS: Financial statements 2021
CVR: 39023636
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Pila Pharma Danmark ApS (CVR 39023636) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -6,366,086 and a net result of DKK -5,052,324 compared with DKK -2,805,709 the year before. Equity in the 2021 report amounted to DKK 1,271,505. The solvency ratio was 87%.
- Gross Profit
- DKK -6,366,086
- Profit/Loss
- DKK -5,052,324
- Equity
- DKK 1,271,505
- Total Assets
- DKK 1,461,073
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -6.4M | -5.1M | 1.3M | - |
| 2020 | - | -3.5M | -2.8M | 854K | 0 |
| 2019 | - | -2.4M | -2.1M | 909K | 1 |
Official annual report
Find more companies like Pila Pharma Danmark ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Pila Pharma Danmark ApS has published its annual report for 2020. Gross profit came to DKK -3,542,401, and the net result was DKK -2,805,709.
About Pila Pharma Danmark ApS
Pila Pharma Danmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Dorte Xenia Gram. The company is owned by Pila Pharma AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,798,283 and a net result of DKK -3,780,896 compared with DKK -3,094,589 the year before. Equity in the 2025 report amounted to DKK 2,596,207.